Microchip patented which separates and extracts tumor cells in the blood
Ikerlan-IK4 and Mondragón Unibertsitatea are taking part in a project initiated by the Spanish National Research Council, CSIC, and which has developed a microchip capable of separating and extracting tumour cells in the blood stream by means of ultrasonic waves. The Foundation General Hospital of the University of Elche, together with researcher Alfredo Carrato, has also collaborated on this project.
The patented microchip has the size of a one euro coin, incorporating a small channel along which a sample of blood containing the patient's tumour cells flows. By means of ultrasonic waves focused on a specific zone, these cells, having a density and size different from the rest, concentrate at the point from where they are gathered.
The device, made of plastic, has potential advantages in the detection of metastasis in its initial phases, and in the control of the effectiveness of the therapy applied to cancer patients. It is made up of an acoustic wave piezoelectric generator, a microchip and a fluidic capsule.
Another of the unique features is that the process is totally non-invasive, given that there is no need to introduce any foreign object into the blood sample in order to detect tumour cells circulating in the blood. Moreover, it maintains the properties of the cells so that subsequent studies or biomolecular analyses can be carried out.
The next stage is developing an industrial-scale prototype. To this end, the research team is already working on perfecting the microchip, and on developing a system for the automatic detection and count of the tumour cells.
Most read news
Organizations
Other news from the department science
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Identifying microbial species
Synapses in 3D - Scientists develop new method to map brain structures
Thermal Properties of Alloys at a Glance
Gyroscopes lead scientists to unusual state of matter in a disorganized structure
Study reveals new method of preparing imaging agents - Dr. Benjamin Rotstein and collaborators unveil an operationally simple method to prepare carbon isotope-labeled versions of drugs and diagnostics
Leading Platform for the Analysis and Biotechnology Industry analytica China 2012 will open in Shanghai in October
Memory loss not enough to diagnose alzheimer's
Nine-Month Figures for 2011: Dynamic, Profitable Growth at Sartorius - Consolidated sales revenue rises 12.2% to 541.4 million euros
Electrochemical sensor for the uncomplicated detection of "hits" on DNA chips
Frozen: Cutting-edge technology reveals structures within cells
Sequenom Announces Exclusive Licensing Agreement with Genomic Nanosystems for Digital PCR Technologies and Methods Patents